AI Summary
We reviewed 38 live results for calcineurin inhibitor and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Immunosuppressant and Calcineurin Inhibitor.
AI Summary
We reviewed 38 live results for calcineurin inhibitor and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Immunosuppressant and Calcineurin Inhibitor.
Comparison Table
Source: Novartis Singapore
Description
A calcineurin inhibitor immunosuppressant used for the prevention of organ rejection in kidney, liver, and heart transplants. It is also indicated for treating various autoimmune diseases and is available in Singapore as capsules or an oral solution for flexible dosing.
Best for
organ transplant recipients, autoimmune disease management, kidney transplant patients and liver transplant patients
Rating
Source: Prograf
Description
A powerful calcineurin inhibitor used primarily for prophylaxis against organ rejection following transplantation. In its topical form (Protopic), it is also used for the management of moderate to severe atopic dermatitis.
Best for
post-transplant care, atopic dermatitis treatment, organ rejection prophylaxis and dermatological conditions
Rating
Source: Lucius Pharmaceuticals (Lao) Co., Ltd.
Description
LuciTofa is an oral medication containing 5mg of Tofacitinib, a Janus kinase (JAK) inhibitor used to treat chronic inflammatory and autoimmune conditions. It is specifically indicated for adult patients suffering from moderately to severely active Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ulcerative Colitis (UC). This prescription medicine is often utilized when traditional therapies like methotrexate have proven inadequate. As a brand-name generic, it provides a therapeutic alternative for managing joint pain, swelling, and bowel inflammation associated with these conditions.
Best for
Rheumatoid Arthritis management, Psoriatic Arthritis relief, Ulcerative Colitis treatment and Patients non-responsive to methotrexate
Rating
| Compare | Sandimmun / Neoral (Cyclosporine) | Prograf / Protopic (Tacrolimus) | LuciTofa (Tofacitinib 5mg) |
|---|---|---|---|
| Source | Novartis Singapore | Prograf | Lucius Pharmaceuticals (Lao) Co., Ltd. |
| Description | A calcineurin inhibitor immunosuppressant used for the prevention of organ rejection in kidney, liver, and heart transplants. It is also indicated for treating various autoimmune diseases and is available in Singapore as capsules or an oral solution for flexible dosing. | A powerful calcineurin inhibitor used primarily for prophylaxis against organ rejection following transplantation. In its topical form (Protopic), it is also used for the management of moderate to severe atopic dermatitis. | LuciTofa is an oral medication containing 5mg of Tofacitinib, a Janus kinase (JAK) inhibitor used to treat chronic inflammatory and autoimmune conditions. It is specifically indicated for adult patients suffering from moderately to severely active Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ulcerative Colitis (UC). This prescription medicine is often utilized when traditional therapies like methotrexate have proven inadequate. As a brand-name generic, it provides a therapeutic alternative for managing joint pain, swelling, and bowel inflammation associated with these conditions. |
| Best for | organ transplant recipients, autoimmune disease management, kidney transplant patients and liver transplant patients | post-transplant care, atopic dermatitis treatment, organ rejection prophylaxis and dermatological conditions | Rheumatoid Arthritis management, Psoriatic Arthritis relief, Ulcerative Colitis treatment and Patients non-responsive to methotrexate |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Sandimmun / Neoral (Cyclosporine) from Novartis Singapore."
I picked this because Highly effective and well-established calcineurin inhibitor registered with the HSA for both organ transplant and autoimmune patients.
Share this search
Related Finds